| Ytd | -59.80% | |
| 1y | -38.96% |
| Open | 4.17 | Prev Close | 4.29 | Low | 4.12 | High | 4.18 | Mkt Cap | 11.14M |
| Vol | 3.14K | Avg Vol | 40.46K | EPS | -2.84 | P/E | -1.45 | Forward P/E | -1.66 |
| Beta | 2.76 | Short Ratio | 3.05 | Inst. Own | 12.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 4.26 | 200-d Avg | 7.30 | 1yr Est | 10.00 |
Initiated activities to resume enrollment in a limited number of U.S. sites in the soft tissue sarco
Company to hold a conference call at 8AM ET on August 11, 2026 to review results and provide a corpo
First patients dosed in SwitzerlandSHELTON, Conn., July 15, 2026 /PRNewswire/ -- Intensity Therapeut
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q